Merit Medical Hypotube Manufacturing Business Is Acquired by Freudenberg Medical

The acquired assets will be absorbed by Cambus Medical located in Galway, Ireland. Cambus Medical, a Freudenberg Medical company, is a market-leading hypotube manufacturer in the minimally invasive industry.

September 8, 2020

Freudenberg Medical, a global developer and manufacturer of specialty components and finished products for the medical device industry, has acquired the dedicated manufacturing equipment and associated assets utilized by Merit Medical Systems, Inc. in its hypotube manufacturing business.

Freudenberg Medical notes the acquired assets will be absorbed by Cambus Medical located in Galway, Ireland. Cambus Medical, a Freudenberg Medical company, is a market-leading hypotube manufacturer in the minimally invasive industry. Established in 2006, Cambus Medical develops and manufactures hypotubes, specialty needles, and metal micro-components for catheters and minimally invasive devices used in diagnostic and therapeutic interventions.

The acquisition includes manufacturing equipment for laser-cut hypotubes and access to additional technology. Merit Medical will supply Cambus Medical with PTFE coated tubing and wire to ensure uninterrupted product supply for all existing customers.

“This transaction is a key step in expanding our leading position in the hypotube market for catheters and other minimally invasive devices,” said Dr. Max Kley, CEO of Freudenberg Medical. “Freudenberg Medical covers the full value chain from supplying mission-critical components like hypotubes to full device manufacturing. This level of vertical integration puts us into a unique position to offer the most advanced technical solutions to our minimally invasive device customers.”

Barry Comerford, CEO of Cambus Medical states, “this strategic acquisition will give Cambus Medical key equipment to increase production capacity, deepen our technology base to achieve unrivaled laser processing and coating capabilities, and expand our customer base.”

Freudenberg Medical’s comprehensive catheter development capabilities include advanced extrusion, handle and shaft development, balloon development and manufacturing, hypotubes and metal micro-components, assembly, and coatings.

More

Artificial Intelligence Tools Make Education Materials More Patient Friendly

“Our study shows that widely used large language models have the potential to transform patient education materials into more readable content, which is essential for patient empowerment and better health outcomes,” said Study senior author Jonah Feldman, MD, medical director of transformation and informatics at NYU Langone.

CorWave Completes 6-Month In Vivo Study for Clinical Trials Initiation

In vivo studies demonstrated the pump’s successful operation for a period of up to six months. Additionally, nine chronic ovine implants were conducted for 60 days with no device failure or sign of thrombosis at explant. These significant milestones mark the final stage of CorWave’s preclinical development, paving the way for its First-In-Human study.